PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-03-19

Date Title Company
19-Mar-2026 Zura Bio Reports Full Year 2025 Financial Results and Recent Corporate Updates Businesswire
19-Mar-2026 QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention Businesswire
19-Mar-2026 Alberta Utilities Collaborating to Reduce Wildfire Risk and Increase Resilience Businesswire
19-Mar-2026 Building Better Bleeding Disorders Therapies With NBDF Patient Panels Businesswire
19-Mar-2026 REGENXBIO, Inc. Stockholders Should Contact Robbins LLP for Information About Leading the RGNX Class Action Businesswire
19-Mar-2026 uniQure N.V. Stockholders Should Contact Robbins LLP for Information About Leading the QURE Class Action Businesswire
19-Mar-2026 n-Lorem Publishes Commentary Offering Insight into Potential Commercialization Strategies for Nano-rare Medicines Businesswire
19-Mar-2026 PSI Reduces Clinical Trial Site Identification From Weeks to Minutes Using AI Agent Powered by Arango Contextual Data Platform Businesswire
19-Mar-2026 Poolbeg Pharma plc - Appointment of Dr Adrian Kilcoyne to Scientific Advisory Board Poolbeg Pharma
19-Mar-2026 Applied Biopharm Consulting Secures IP Start Grant for AI-Driven Capsid Engineering Applied Biopharm
19-Mar-2026 UK cleanroom specialist Total Clean Air appointed European partner for US bio-decontamination firm TOMI Total Clean Air
19-Mar-2026 Lundbeck appoints Chief AI Officer Lundbeck
19-Mar-2026 ReNeuron establishes new base at Swansea University’s Institute of Life Science in major research partnership ReNeuron
19-Mar-2026 Medidata and CRIO Empower Over 2,500 Global Research Sites with Seamless Integration to Accelerate Clinical Trials Medidata
19-Mar-2026 Biotium's New Cell Barcoding Kit Streamlines Flow Cytometry with 15-Sample, Single-Tube Multiplexing Biotium
19-Mar-2026 Ondine Biomedical Hits 93% Enrolment Milestone in Landmark Phase 3 U.S. Clinical Study for Steriwave® Ondine Biomedical
19-Mar-2026 Ryvu Therapeutics to Present Preclinical Data on the ONCO Prime Platform at the 2026 AACR Annual Meeting and Announces PERO Grant Agreement Ryvu Therapeutics
19-Mar-2026 Touchlight and New England Biolabs® Unveil EnClose™ Cell-free dbDNA™ Synthesis Kit to Accelerate Next Generation DNA and RNA Therapeutic Development Touchlight
19-Mar-2026 Atrogi announces first subjects dosed in human trial for lead candidate ATR-258 Atrogi
19-Mar-2026 Kupando Secures Additional €10 Million in Series A Financing to Advance Novel Immuno-Oncology and Infectious Diseases Programs Kupando